Tag: Cancer: Lymphoma
Brentuximab Vedotin + Chemo Ups Event-Free Survival in Peds Hodgkin Lymphoma
Event-free survival rate higher in pediatric patients, but no difference seen in the percentage of patients receiving involved-site radiation therapy
Tumefactive Demyelinating Lesions, Sentinel Lesions of PCNSL Compared
Age of onset younger for tumefactive demyelinating lesions than for primary central nervous system lymphoma
Incidence of Cutaneous T-Cell Lymphoma Up in the U.S.
Overall incidence rate six times higher for patients aged 40 years or older versus younger than 40 years, but increase in CTCL rate significantly higher for those younger than 40 years
FDA Warns of Rare Cases of Certain Cancers Linked to Breast Implants
Federal regulators discovered reports of the cancers as part of a routine postmarket review
Polypharmacy Prevalent Among Older Adults With Blood Cancers
Taking eight or more medications strongly associated with frailty; odds of being prefrail, frail increased with each additional med
Survival Advantage Seen for A+ADV in Advanced Hodgkin Lymphoma
Progression-free survival longer for brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine versus ABVD
In AIDS-Related Lymphoma, Outcomes Worse With Hypoalbuminemia
AIDS-related lymphoma patients with hypoalbuminemia show worse overall survival, two-year progression-free survival
Dual Effect Identified for Arsenic in Carcinogenesis
Arsenic level in drinking water negatively associated with incidences of lymphoma, leukemia in men and women
ASCO: Add-On Ibrutinib Slows Mantle-Cell Lymphoma in Older Adults
Addition of ibrutinib to chemoimmunotherapy prolongs progression-free survival in older patients with untreated mantle-cell lymphoma
AACR: Novel COVID-19 Vaccine Aimed at Immunocompromised Patients
CoVac-1, a peptide vaccine, induces T-cell immune responses in those with B-cell deficiencies, particularly leukemia and lymphoma patients
